5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines

Lindsay P. Cameron(University of California, Davis), David E. Olson(Multidisciplinary Association for Psychedelic Studies), Maxemiliano V. Vargas(University of California, Davis), Hunter T. Warren(Multidisciplinary Association for Psychedelic Studies), Hannah N. Saeger(University of California, Davis), Winston L. Chow(Multidisciplinary Association for Psychedelic Studies), Eden V. Barragan(University of California, Davis), J.A. Gray(University of California, Davis), Seona D. Patel(University of California, Davis)
ACS Chemical Neuroscience
January 11, 2023
10.1021/acschemneuro.2c00718
Cited by 110

Related Papers

Psychedelics Promote Structural and Functional Neural Plasticity
|Cell Reports|2018|1.1k
A non-hallucinogenic psychedelic analogue with therapeutic potential
|Nature|2020|461
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
|Science|2023|455
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
|ACS Pharmacology & Translational Science|2020|326
The neural basis of psychedelic action
|Nature Neuroscience|2022|286